Vertex Pharmaceuticals (VRTX)
(Real Time Quote from BATS)
$464.52 USD
+4.52 (0.98%)
Updated Sep 24, 2024 01:36 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $4.11 | -0.85% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of -$12.83 per share, missing the Zacks Consensus Estimate of -$11.50 per share. This reflects a negative earnings surprise of 11.57%. Look out for VRTX's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $4.11 per share, reflecting a year-over-year increase of .74%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services